Oncolytics Biotech (ONCY) Misses Q3 EPS by 2c

Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Qualcomm (QCOM) PT Raised to $195 at BofA Securities
• ZenaTech raises Plurilock Security stake to 12% with new share purchase